Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches

Michael Orth(Deutschen Konsortium für Translationale Krebsforschung), Kirsten Lauber(Ludwig-Maximilians-Universität München)

Radiation Oncology

August 8, 2019

10.1186/s13014-019-1345-6

Cited by 484

Related Papers

Combination of 5-Fluorouracil with Epigenetic Modifiers Induces Radiosensitization, Somatostatin Receptor 2 Expression, and Radioligand Binding in Neuroendocrine Tumor Cells In Vitro

|Journal of Nuclear Medicine|2019|46

A novel HSP90 inhibitor with reduced hepatotoxicity synergizes with radiotherapy to induce apoptosis, abrogate clonogenic survival, and improve tumor control in models of colorectal cancer

|Oncotarget|2016|24